3 studies on Ghrh pathway mechanism curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
**Continuous or prolonged central exposure to GH secretagogues drives desensitization**, not sensitization — a direct challenge to the assumption that chronic dosing linearly amplifies GH output. For peptide users and…
**Clinicians and peptide users combining GHS with GHRH analogs** (e.g., sermorelin or CJC-1295) should note the synergistic GH release depends entirely on hypothalamo-pituitary integrity — individuals with hypothalami…
**The central mechanism of GH secretagogues does not depend on intact noradrenergic circuitry**, which has direct implications for clinical and research contexts in which noradrenergic tone is altered — such as stress…